Atlas Venture Raises $400M for Third Opportunity Fund to Boost…

Team S · 2025-09-05T09:36:16.000Z

Atlas Venture, a prominent biotech venture capital firm, has raised $400 million for its third Opportunity Fund. This fund will provide growth capital to existing biotech startups in Atlas' portfolio, supporting their development in a challenging funding environment. The initiative reflects Atlas' strategy to bolster promising companies, such as Alnylam Pharmaceuticals and Mariana Oncology, amidst a biotech market downturn. This follows their $450 million Fund XIV raised in December 2024

Member Login Get Access

Atlas Venture Raises $400M for Third Opportunity Fund to Boost… | Newnex